Main Logo
Menu
About Us
Our Philosophy
The Industry and Us
Our Strategy
Our Technology
Key Applications
Clinical Programs
Preclinical Programs
Pipeline
Our Partnerships
Our Team
Executive Management
Board of Directors
Clinical Advisory Board
Media / Science Center
Contact Us
Investors
All SEC Filings
Investors
Investors
Overview
News
Press Releases
Email Alerts
In The News
Videos
Events & Presentations
Events
Presentations
Financial Info
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
Filings & Financials
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
Management Team
Investor Resources
Contacts
Email Alerts
FAQs
Investor Fact Sheet
Filing Type:
View All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
424B8
425
8-A12B
8-A12G
8-A12G/A
8-K
8-K/A
ARS
AW
CERTNAS
CORRESP
D
DEF 14A
DEFA14A
DEL AM
DRS
EFFECT
NT 10-Q
POS AM
POS EX
PRE 14A
PREM14A
PRER14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
Date
Form
Description
PDF
XBRL
Pages
02/13/20
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
10
02/11/20
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
37
02/11/20
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
5
02/11/20
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Documents
expand_more
EX-99.1
42
02/11/20
8-K
Current report filing
Documents
expand_more
EX-99.1
42
02/06/20
8-K
Current report filing
3
01/31/20
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Documents
expand_more
EX-10.1
28
01/31/20
8-K
Current report filing
Documents
expand_more
EX-10.1
28
01/31/20
PREM14A
Preliminary proxy statement relating to a merger, acquisition, or disposition
756
01/27/20
425
Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions
Documents
expand_more
EX-99.1
43
rss_feed
Filing RSS
Previous Page
arrow_back
Page
1
…
Page
33
Page
34
Page
35
Page
36
Page
37
Page
38
Page
39
Page
40
Page
41
Page
42
…
Page
47
Next Page
arrow_forward
Email Alerts
Company Profile
Contacts
RSS News Feed